France’s HRA Pharma lifts sales by a fifth in 2019
12 March 2020
Acquiring the Mederma skincare brand helped HRA Pharma increase its worldwide sales by 21% to EUR254 million (USD279 million) in 2019.
Industry News - Tag: HRA Pharma
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
HRA Pharma forms Chinese joint venture with Profex
Premium
14 January 2020
France’s HRA Pharma is stepping up its presence in China through a new subsidiary in Shanghai and a joint venture with specialty healthcare company Profex.
HRA expands into Middle East with Compeed
Premium
19 December 2019
France's HRA Pharma is expanding into the Middle East with its Compeed blister care brand.
ellaOne wins European Marketing Campaign of Year
3 December 2019
HRA Pharma’s new multi-country marketing campaign for its ellaOne (ulipristal acetate) emergency contraceptive captures the OTCToolbox Consumer Healthcare Industry (CHi) Award for European Marketing Campaign of the Year.
HRA Pharma separates rare diseases portfolio
Premium
15 July 2019
HRA Pharma has put its medicines for rare diseases into a separate affiliate, as the French company focuses on expanding its consumer healthcare business.
HRA grows consumer business with Mederma
Premium
29 April 2019
France's HRA Pharma is set to acquire global rights to the Mederma skincare brand from Merz Pharmaceuticals for an undisclosed sum. The deal also includes the Eldertonic and Nu-Iron vitamins, minerals and supplements (VMS) brands.
HRA Pharma runs contraception hackathon
9 April 2019
A recent hackathon organised by HRA Pharma produced 14 potential digital solutions that could improve the contraception journey for women.
Compeed transforms HRA Pharma in 2018
Premium
5 April 2019
Acquiring the Compeed brand helped HRA Pharma increase its worldwide sales by 72% to EUR210 million (USD237 million) in 2018.